TrialClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2020

A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).

Cary D Austin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.